Targeting constitutively active <scp>STAT3</scp> in chronic lymphocytic leukemia: A clinical trial of the <scp>STAT3</scp> inhibitor pyrimethamine with pharmacodynamic analysesJennifer R. Brown, David A. Frank, Stacey M. Fernandes et al.|American Journal of Hematology|2020Cited by 29